| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/15/1996 | WO1995019169A3 Treatment of platelet derived growth factor related disorders such as cancer using inhibitors of platelet derived growth factor receptor |
| 02/15/1996 | DE4428402A1 Gentherapeutisches Verfahren unter Verwendung von DNA-Vektoren ohne Selektionsmarker-Gen Gene therapy methods using DNA vectors without selectable marker gene |
| 02/15/1996 | CA2196562A1 Highly bioadhesive and mucoadhesive compositions for the treatment of epithelia and mucous membranes |
| 02/15/1996 | CA2173221A1 Apparatus and method for preparing solid forms with controlled release of the active ingredient |
| 02/14/1996 | EP0696598A1 Polysaccharide esters and their salts |
| 02/14/1996 | EP0696453A2 Pediatric lipid emulsion |
| 02/14/1996 | EP0696452A1 Nanoemulsion of the oil in water type, useful as an ophthalmic vehicle and process for the preparation thereof |
| 02/14/1996 | EP0696208A1 Oral drug delivery compositions and methods |
| 02/14/1996 | EP0696200A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 02/14/1996 | EP0696192A1 Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
| 02/14/1996 | EP0696191A1 Particulate vector and pharmaceutical composition containing such vector |
| 02/14/1996 | EP0696190A1 Nasal aromatic releasing compositions |
| 02/14/1996 | CN1116823A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 02/14/1996 | CN1116540A Fetal conversion plaster by sticking on acupoint |
| 02/14/1996 | CN1116531A Process for preparing "Wujisan" granule |
| 02/14/1996 | CN1116525A 透皮吸收制剂 Transdermal preparations |
| 02/14/1996 | CN1116524A Formes galeniques a liberation prolongee du chlorhydrate d'alfuzosine |
| 02/14/1996 | CN1116523A Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract |
| 02/14/1996 | CN1116522A Stable freeze-dried formulation comprising a protein assay kit |
| 02/14/1996 | CN1116521A Sustained release compositions and a method of preparing pharmaceutical compositions |
| 02/14/1996 | CN1116520A Skin protecting composition containing acid hydrophilic agent for cosmetic use and application of same |
| 02/14/1996 | CN1116495A Fever reducing tea |
| 02/14/1996 | CN1030964C Task-masking composition of bitter pharmaceutical agents |
| 02/13/1996 | US5491171 Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
| 02/13/1996 | US5491154 A premixes of nimodipine, citric acid, sodium bicarbonate, citrus flavor and organe granules; solubility |
| 02/13/1996 | US5490993 Method of preparing a proteinaceous food product containing a melt spun matrix and product thereof |
| 02/13/1996 | US5490990 Production of solid pharmaceutical depot forms |
| 02/13/1996 | US5490989 Holder and packaging for a hardened medicated matrix |
| 02/13/1996 | US5490988 Delivery of therapeutic agents to a target site |
| 02/13/1996 | US5490987 Tableting of colestipol hydrochloride |
| 02/13/1996 | US5490986 Synthetic blood |
| 02/13/1996 | US5490985 Extended duration antacid product |
| 02/13/1996 | US5490980 Transglutaminase crosslinks proteins by catalyzing the active ingrediants to glutamine residues |
| 02/13/1996 | US5490962 Computer aided design; stereolithography, selective laser sintering, three-dimensional printing |
| 02/13/1996 | US5490498 Adding fluorocarbon along with breathing gas which oxygenates the fluorocarbon; treatment of respiratory distress syndrome |
| 02/13/1996 | CA2090422C Pharmaceutical composition of florfenicol |
| 02/13/1996 | CA2035841C Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture |
| 02/13/1996 | CA2032592C Dual subcoated simulated capsule-like medicament |
| 02/08/1996 | WO1996003653A1 Superparamagnetic particles, process for their production and their use |
| 02/08/1996 | WO1996003414A1 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression |
| 02/08/1996 | WO1996003205A1 Preparation of cells or dispersed active substances into micro-encapsulated form and thus obtained micro-capsules |
| 02/08/1996 | WO1996003147A1 Synthesis of chemical gels from polyelectrolyte polysaccharides by gamma-irradiation |
| 02/08/1996 | WO1996003142A1 Drug delivery composition for the nasal administration of antiviral agents |
| 02/08/1996 | WO1996003135A1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients |
| 02/08/1996 | WO1996003131A1 Percutaneously absorbable preparation |
| 02/08/1996 | WO1996003128A1 Preparation of fusidic acid tablets |
| 02/08/1996 | WO1996003121A1 Antiphlogistic, analgesic, antipyretic injection preparation |
| 02/08/1996 | WO1996003119A1 Transdermal delivery device containing an estrogen |
| 02/08/1996 | WO1996003118A1 Food-like drug |
| 02/08/1996 | WO1996003117A1 Incorporation of biologically active molecules into bioactive glasses |
| 02/08/1996 | WO1996003116A1 Controlled release of metal cation-stabilized interferon |
| 02/08/1996 | WO1996003115A1 Aqueous foamable composition |
| 02/08/1996 | WO1996003114A1 Lock and key micelles |
| 02/08/1996 | WO1996003113A1 Self-emulsifying drug delivery system |
| 02/08/1996 | WO1996003112A1 Compositions comprising a tissue glue and therapeutic agents |
| 02/08/1996 | WO1996003111A1 Pharmaceutical compositions based on chewing gum and a method for the preparation thereof |
| 02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |
| 02/08/1996 | DE4437442A1 Verfahren zur Herstellung von Manteltabletten A process for the production of coated tablets |
| 02/08/1996 | DE4428851A1 Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie Iron-containing nanoparticles, their preparation and use in the diagnosis and treatment |
| 02/08/1996 | DE4428056A1 Verwendung von Mikropartikelpräparationen zur Eliminierung gelöster, nicht nierengängiger Substanzen aus dem Blut Use of microparticle preparations for eliminating the dissolved, non-renal common substances from the blood |
| 02/08/1996 | DE4418936A1 Polypeptid Polypeptide |
| 02/08/1996 | CA2195994A1 Controlled release of metal cation-stabilized interferon |
| 02/08/1996 | CA2195980A1 Lock and key micelles |
| 02/08/1996 | CA2195748A1 Percutaneously absorbable preparation |
| 02/08/1996 | CA2195680A1 Incorporation of biologically active molecules into bioactive glasses |
| 02/08/1996 | CA2195639A1 Drug delivery composition for the nasal administration of antiviral agents |
| 02/08/1996 | CA2195623A1 Self-emulsifying drug delivery system |
| 02/08/1996 | CA2170413A1 Pharmaceutical compositions based on chewing gum and a method for the preparation thereof |
| 02/07/1996 | EP0746301A4 Self-tanning cosmetic compositions and methods of using the same |
| 02/07/1996 | EP0695551A2 Laxative composition containing a bulk laxative and a lubricating laxatif |
| 02/07/1996 | EP0695549A1 Use of polydeoxyribonucleotides in diabetic neuropathies |
| 02/07/1996 | EP0695548A1 A stably storable and readily water soluble composition of cephalosporin for injections |
| 02/07/1996 | EP0695546A1 Powders based on metoclopramide and paracetamol or acetylsalicylic acid derivatives |
| 02/07/1996 | EP0695545A1 Use of diphenylethane derivatives for the treatment of glaucoma |
| 02/07/1996 | EP0695544A1 Hard gelatin capsules resistant to denaturation and the production thereof |
| 02/07/1996 | EP0695195A1 Polymeric x-ray contrast compositions containing iodinated polymeric beads |
| 02/07/1996 | EP0695186A1 Ocular delivery of nucleic acid |
| 02/07/1996 | EP0695182A1 Systems for controlled release of pilocarpine |
| 02/07/1996 | EP0695181A1 Methods of using hesperetin for sebum control and treatment of acne |
| 02/07/1996 | EP0695179A1 Transdermal antiinflammatory composition |
| 02/07/1996 | EP0695177A1 Active substance-containing plaster |
| 02/07/1996 | EP0695176A1 Solid form of administration of isosorbide 5-mononitrate |
| 02/07/1996 | EP0695175A1 Coated pharmaceutical compositions |
| 02/07/1996 | EP0695174A1 Multi-stage drug delivery system |
| 02/07/1996 | EP0695173A1 Manufacturing matrices |
| 02/07/1996 | EP0695172A1 High release solid preparation, preparation and use thereof |
| 02/07/1996 | EP0695170A1 Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles |
| 02/07/1996 | EP0695169A1 Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use |
| 02/07/1996 | EP0637235B1 Oral suspension formulation |
| 02/07/1996 | EP0627915A4 Sprayable analgesic composition and method of use. |
| 02/07/1996 | EP0580689B1 Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material |
| 02/07/1996 | EP0499619B1 Method for producing protein microspheres |
| 02/07/1996 | EP0491921B1 Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance |
| 02/07/1996 | EP0470251B1 Liquid prostaglandin composition |
| 02/07/1996 | CN1116407A Preservative system for contact lens solutions |
| 02/07/1996 | CN1116406A Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
| 02/07/1996 | CN1116212A Prolonged release preparation and polymers thereof |
| 02/07/1996 | CN1116102A Plaster for sequelae of brain palsy |
| 02/07/1996 | CN1116099A Medicinal powder of Rhodiola rosea L. |
| 02/07/1996 | CN1116098A Medicinal composition for tympanitis |